Pfizer (PFE) Tops Q1 EPS by 2c, Revenues Miss; Reaffirmed Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
PFIZER REPORTS FIRST-QUARTER 2018 RESULTS
May 1, 2018 6:45 AM EDTFirst-Quarter 2018 Revenues of $12.9 Billion First-Quarter 2018 Reported Diluted EPS(1) of $0.59, Adjusted Diluted EPS(2) of $0.77 Reaffirmed All Components of 2018 Financial Guidance
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2018 and reaffirmed all components of 2018 financial guidance.
Results for the first quarter of 2018 and 2017(3) are summarized below.
OVERALL RESULTS Â($ in millions, except per share amounts)
 First-Quarter 2018   2017   Change Revenues  $  12,906    $  12,779    1% Reported Net Income(1) 3,561 3,121 14% Reported Diluted EPS(1) 0.59 0.51 15% Adjusted Income(2) 4,668 4,192 11% Adjusted Diluted EPS(2) 0.77 0.69 12% ÂREVENUES
 ... More
